Artia Global Partners »

Bright Minds Biosciences shares owned by Artia Global Partners

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 33k 78.04

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
BlackRock
Braidwell
MPM Oncology Impact Management
Sio Capital Management
Balyasny Asset Management
Ikarian Capital
Eventide Asset Management
Stempoint Capital
Longwood Capital Partners
State Street Corporation

View all funds holding Bright Minds Biosciences